|
|
|
Volumn 12 Suppl 1, Issue , 2005, Pages
|
|
New treatments for metastatic kidney cancer.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
ADJUVANT CHEMOTHERAPY;
ADULT;
AGED;
CANCER STAGING;
COMPARATIVE STUDY;
FEMALE;
HUMAN;
IMMUNOTHERAPY;
KIDNEY CARCINOMA;
KIDNEY TUMOR;
MALE;
METASTASIS;
METHODOLOGY;
MIDDLE AGED;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
PROGNOSIS;
REVIEW;
RISK ASSESSMENT;
SENSITIVITY AND SPECIFICITY;
SURVIVAL;
TREATMENT OUTCOME;
ADULT;
AGED;
ANGIOGENESIS INHIBITORS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, RENAL CELL;
CHEMOTHERAPY, ADJUVANT;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
IMMUNOTHERAPY;
KIDNEY NEOPLASMS;
MALE;
MIDDLE AGED;
NEOPLASM METASTASIS;
NEOPLASM STAGING;
PROGNOSIS;
RISK ASSESSMENT;
SENSITIVITY AND SPECIFICITY;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
|
EID: 18244374789
PISSN: 11959479
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (29)
|
|
References (32)
|
